抑制恐惧记忆提取诱导的少突胶质细胞生成可挽救PTSD样行为
该研究建立重复恐惧提取小鼠模型模拟PTSD再体验症状,发现重复恐惧提取可强化远期恐惧记忆并导致焦虑样行为和社交偏好缺陷,伴随区域特异性少突胶质细胞生成、恐惧提取相关印迹细胞再激活增强及树突棘密度增加。通过诱导新少突胶质细胞凋亡或Olig2条件性敲除抑制少突胶质细胞生成,可减轻远期恐惧记忆异常强化和社交缺陷,Olig2 cKO还缓解焦虑样行为。雷帕霉素在重复恐惧提取期间给药可重现抗髓鞘化效应,提示抑制少突胶质细胞生成是PTSD的潜在治疗策略。
要点
- 重复恐惧提取可强化远期恐惧记忆并诱发焦虑样行为和社交偏好缺陷。
- 抑制少突胶质细胞生成(凋亡诱导或Olig2 cKO)可减轻恐惧记忆强化和社交缺陷。
- 雷帕霉素在恐惧提取期给药可重现抗髓鞘化对行为缺陷的改善效应。
核心结论
- 重复恐惧提取诱导的少突胶质细胞生成足以驱动PTSD样行为进展,可能通过调节成人恐惧环路的神经元活动和树突棘密度实现。
- 在恐惧提取阶段药物抑制少突胶质细胞生成是预防远期恐惧记忆病理性强化及焦虑样行为和社交偏好缺陷的有前景治疗策略。
研究设计与样本
- 研究建立重复恐惧提取小鼠模型以模拟PTSD患者的再体验症状。
- 采用细胞谱系追踪和标记技术观察少突胶质细胞生成及印迹细胞再激活。
- 通过诱导新少突胶质细胞凋亡和Olig2条件性敲除进行功能缺失实验。
- 在重复恐惧提取期间给予雷帕霉素进行药理学抑制实验。
主要发现
- 重复恐惧提取可强化远期恐惧记忆,并导致焦虑样行为和社交偏好缺陷。
- 重复恐惧提取伴随区域特异性少突胶质细胞生成、恐惧提取相关印迹细胞再激活增强及树突棘密度增加。
- 诱导新少突胶质细胞凋亡或Olig2 cKO显著减轻远期恐惧记忆异常强化和社交缺陷。
- Olig2 cKO抑制少突胶质细胞生成还可缓解焦虑样行为。
- 新形成少突胶质细胞减少可降低恐惧提取诱导的恐惧相关脑区神经元激活和树突棘密度。
临床怎么用
- 在PTSD再体验症状反复出现阶段,可考虑靶向抑制少突胶质细胞生成以预防远期恐惧记忆病理性强化。
- 雷帕霉素等少突胶质细胞生成抑制剂在恐惧提取期给药可能改善焦虑样行为和社交偏好缺陷。
局限性
- 研究基于小鼠重复恐惧提取模型,结论向PTSD患者外推需进一步临床验证。
- 雷帕霉素为工具性抑制剂,其临床转化需评估安全性和剂量方案。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Recurrent re-experiencing traumatic memory is known as a common symptom in post-traumatic stress disorder (PTSD) patients, and its severity is closely related to the progression and prognosis of PTSD. Notably, some individuals with PTSD exhibit white matter abnormalities. Myelin constitutes a critical structure within white matter, and myelination in the adult brain has been demonstrated to actively regulate the consolidation of remote memories. However, the dynamics of myelin after re-experiencing traumatic stressors and their functional significance remain largely unexplored. Here, we developed a repeated fear recall mouse model to mimic re-experiencing symptoms in PTSD patients, and found that repeated fear recall can reinforce remote fear memory while cause anxiety-like behaviors and social preference deficits. This coincides with region-specific oligodendrogenesis, heightened reactivation of fear recall-associated engram cells, and an increase in dendritic spine density, demonstrated through cell-lineage tracing and labeling. We hypothesize that oligodendrogenesis driven by repeated fear recall is sufficient to regulate remote fear memory and behavioral abnormalities. Loss-of-function experiments, either inducing apoptosis of new oligodendrocytes (OLs) or cell-type-specific knocking out (cKO) oligodendroglial transcription factor 2 (Olig2), significantly attenuated the abnormal reinforcement of remote fear memory and ameliorated social deficits induced by repeated fear recall. Moreover, inhibiting oligodendrogenesis through Olig2 cKO relieved anxiety-like behavior. Notably, diminished newly formed OLs also decreases fear recall-induced neuronal activation and dendritic spine density in fear-related brain regions. More importantly, administering rapamycin, a potent inhibitor of oligodendrogenesis, during repeated fear recalls phenocopies the effects of anti-myelination on fear memory-related behavioral defects. In summary, our findings demonstrate that oligodendrogenesis induced by repeated fear recall is sufficient to drive the progression of PTSD-like behaviors, likely by modulating neuronal activity and dendritic spine density within the adult fear circuitry. Pharmacological treatments that inhibiting oligodendrogenesis during the recall phase represent a promising therapeutic strategy for preventing the pathological reinforcement of long-term fear memories, thereby averting the emergence of anxiety-like behaviors and social preference deficits in individuals with PTSD. Schematic image summarizing the major findings of the present study.
引用
- Feng J, Huang NX, Liu K, et al. Inhibiting fear memory recall-induced oligodendrogenesis rescues PTSD-like behaviors. Mol Psychiatry. 2026. PMID: 42304067. doi:10.1038/s41380-026-03688-z
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。